Dykes D C, Brandt-Rauf P, Luster S M, Chung D, Friedman F K, Pincus M R
Department of Pathology, SUNY Health Science Center, Syracuse 13210.
J Biomol Struct Dyn. 1992 Jun;9(6):1025-44. doi: 10.1080/07391102.1992.10507977.
A complete three-dimensional structure for the ras-gene-encoded p21 protein with Gly 12 and Gln 61, bound to GDP, has been constructed in four stages using the available alpha-carbon coordinates as deposited in the Brookhaven National Laboratories Protein Data Bank. No all-atom structure has been made available despite the fact that the first crystallographic structure for the p21 protein was reported almost four years ago. In the p21 protein, if amino acid substitutions are made at any one of a number of different positions in the amino acid sequence, the protein becomes permanently activated and causes malignant transformation of normal cells or, in some cell lines, differentiation and maturation. For example, all amino acids except Gly and Pro at position 12 result in an oncogenic protein; all amino acids except Gln, Glu and Pro at position 61 likewise cause malignant transformation of cells. We have constructed our all-atom structure of the non-oncogenic protein from the x-ray structure in order to determine how oncogenic amino acid substitutions affect the three-dimensional structure of this protein. In Stage 1 we generated a poly-alanine backbone (except at Gly and Pro residues) through the alpha-carbon structure, requiring the individual Ala, Pro or Gly residues to conform to standard amino acid geometry and to form trans-planar peptide bonds. Since no alpha-carbon coordinates for residues 60-65 have been determined, these residues were modeled by generating them in the extended conformation and then subjecting them to molecular dynamics using the computer application DISCOVER and energy minimization using DISCOVER and the ECEPP (Empirical Conformational Energies for Peptides Program). In Stage 2, the positions of residues that are homologous to corresponding residues of bacterial elongation factor Tu (EF-Tu) to which p21 bears an overall 40% sequence homology, were determined from their corresponding positions in a high-resolution structure of EF-Tu. Non-homologous loops were taken from the structure generated in Stage 1 and were placed between the appropriate homologous segments so as to connect them. In Stage 3, all bad contacts that occurred in this resulting structure were removed, and the coordinates of the alpha-carbon atoms were forced to superimpose as closely as possible on the corresponding atoms of the reference (x-ray) structure. Then the side chain positions of residues of the non-homologous loop regions were modeled using a combination of molecular dynamics and energy minimization using DISCOVER and ECEPP respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
利用布鲁克海文国家实验室蛋白质数据库中已存入的α-碳原子坐标,分四个阶段构建了与GDP结合的、具有甘氨酸12和谷氨酰胺61的ras基因编码的p21蛋白的完整三维结构。尽管p21蛋白的第一个晶体学结构在近四年前就已报道,但目前尚未有全原子结构公布。在p21蛋白中,如果在氨基酸序列的多个不同位置中的任何一个位置进行氨基酸替换,该蛋白就会永久激活,导致正常细胞发生恶性转化,或者在某些细胞系中引起分化和成熟。例如,第12位除甘氨酸和脯氨酸外的所有氨基酸都会产生致癌蛋白;第61位除谷氨酰胺、谷氨酸和脯氨酸外的所有氨基酸同样会导致细胞发生恶性转化。我们根据X射线结构构建了非致癌蛋白的全原子结构,以确定致癌氨基酸替换如何影响该蛋白的三维结构。在第一阶段,通过α-碳原子结构生成了一个聚丙氨酸主链(甘氨酸和脯氨酸残基除外),要求单个丙氨酸、脯氨酸或甘氨酸残基符合标准氨基酸几何形状并形成反式平面肽键。由于尚未确定第60 - 65位残基的α-碳原子坐标,这些残基通过以伸展构象生成,然后使用计算机应用程序DISCOVER进行分子动力学模拟,并使用DISCOVER和ECEPP(肽的经验构象能量程序)进行能量最小化来建模。在第二阶段,根据p21与细菌延伸因子Tu(EF - Tu)具有40%序列同源性的相应残基的位置,从EF - Tu的高分辨率结构中的相应位置确定同源残基的位置。非同源环取自第一阶段生成的结构,并放置在适当的同源片段之间以连接它们。在第三阶段,去除此结构中出现的所有不良接触,并迫使α-碳原子的坐标尽可能紧密地叠加在参考(X射线)结构的相应原子上。然后分别使用DISCOVER和ECEPP,通过分子动力学和能量最小化相结合的方法对非同源环区域残基的侧链位置进行建模。(摘要截断于400字)